Awards
5
Seller Intelligence Snapshot
| What this means | Value |
|---|---|
| Dependence on biggest customer | 100.0% (High dependence) |
| Dependence on biggest sector | 100.0% (High dependence) |
| Customer concentration score | 10000.0 (High concentration) |
| Sector concentration score | 10000.0 (High concentration) |
Interpretation: a higher concentration score means awards are concentrated in fewer buyers or sectors.
Page 1 of 1 (5 total)
| Title | Status | Buyer | Value | Sector | Source | Published | |
|---|---|---|---|---|---|---|---|
| NP49425 Generic and Biosimilar Transition Medicines | complete | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | £26,539,272 | Pharmaceutical products | Find a Tender | 19 Dec 2025, 16:55 | View notice |
| Leuprorelin (Prostap®) | complete | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | £2,625,907 | Pharmaceutical products | Find a Tender | 02 Dec 2025, 08:51 | View notice |
| Leuprorelin (Prostap®) | complete | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | £2,625,907 | Pharmaceutical products | Find a Tender | 05 Nov 2025, 12:48 | View notice |
| NP48925d Hereditary Angioedema Branded Medicines (Cinryze and Takhzyro) | complete | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | £9,461,556 | Pharmaceutical products | Find a Tender | 02 May 2025, 12:35 | View notice |
| NP48925d Hereditary Angioedema Branded Medicines (Cinryze and Takhzyro) | complete | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | £9,461,556 | Pharmaceutical products | Find a Tender | 04 Apr 2025, 14:31 | View notice |
Page 1 of 1 (1 buyers)
| Buyer | Award Count | Known GBP | Most Recent Award | Sector Concentration | Opportunities |
|---|---|---|---|---|---|
| The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | 5 | £50,714,198 | 19 Dec 2025, 16:55 | Pharmaceutical products | View notices |
Loading competitor overlaps...
| Sector | Notices | Opportunities |
|---|---|---|
| Pharmaceutical products | 5 | View notices |
| Sector | Known GBP | Notices | Opportunities |
|---|---|---|---|
| Pharmaceutical products | £50,714,198 | 5 | View notices |
| CPV Code | Description | Notices | Known GBP | Opportunities |
|---|---|---|---|---|
| 33600000 | Pharmaceutical products | 5 | £50,714,198 | View notices |
| Month | Total | Open | Awarded | Known GBP |
|---|---|---|---|---|
| Apr 2025 | 1 | 0 | 1 | £9,461,556 |
| May 2025 | 1 | 0 | 1 | £9,461,556 |
| Nov 2025 | 1 | 0 | 1 | £2,625,907 |
| Dec 2025 | 2 | 0 | 2 | £29,165,179 |
Months active in last 12: 4. Longest active streak: 2 months.
Known GBP coverage: 100.0% of notices have known GBP values.
Buyer attribution coverage: 100.0% of notices have buyer names populated.